Comparative Human Enhancement Law

1. Meaning and Concept

Human enhancement law refers to the legal rules and principles governing technologies or interventions intended not merely to treat disease or restore normal functioning, but to improve, augment, extend, or transform human physical, cognitive, genetic, sensory or reproductive capacities.

Examples include:

genetic enhancement and CRISPR gene editing;

enhancement of intelligence, memory or concentration;

neurotechnology and brain-computer interfaces;

pharmacological enhancement;

performance-enhancing substances;

prosthetic and bionic augmentation;

reproductive and embryo selection technologies;

anti-ageing and longevity interventions;

cosmetic enhancement;

human-machine integration;

cognitive enhancement through neural implants.

There is no single comprehensive “Human Enhancement Act” in most jurisdictions. Instead, enhancement is regulated through constitutional rights, medical law, criminal law, biomedical research rules, product regulation, privacy/data law, patent law, reproductive law and sports regulations.

A particularly important distinction is:

Therapy seeks to restore or maintain health; enhancement seeks to improve a capacity beyond the ordinary therapeutic baseline.

The distinction is not always legally clear. A technology such as gene editing may be therapeutic in one context and enhancement-oriented in another.

2. Why Human Enhancement Creates Legal Problems

Human enhancement raises several competing legal values:

Individual autonomy – Should an adult have freedom to modify their own body?

Informed consent – Does the person understand long-term risks?

Human dignity – Are there limits to treating the human body as a technological object?

Equality – Will wealthy persons obtain biological advantages unavailable to others?

Safety – Who bears responsibility for unforeseen side effects?

Children's rights – Can parents consent to irreversible enhancement of children?

Future generations – Can parents legally make inheritable genetic changes?

Privacy – Who controls genetic, neural and biometric information?

Non-discrimination – Could enhanced and unenhanced persons be treated differently?

Sports integrity – Should biological enhancement be prohibited in competition?

Commercial exploitation – Can companies commercialise human biological characteristics?

Human identity – At what point does enhancement fundamentally change the legal concept of the person?

3. Main Categories of Human Enhancement

4. Comparative Legal Framework

A. India

India does not presently have a single comprehensive human-enhancement statute. Regulation is distributed across:

Constitution of India;

medical-consent principles;

Medical Devices Rules;

Drugs and clinical-trial regulation;

Assisted Reproductive Technology (Regulation) Act, 2021;

Surrogacy (Regulation) Act, 2021;

Biomedical and Health Research regulations;

Information Technology and data-protection law;

criminal law;

consumer protection law;

professional medical regulation.

Indian constitutional jurisprudence is especially important because privacy, dignity, bodily autonomy and decisional autonomy provide the conceptual foundation for enhancement law.

In K.S. Puttaswamy, the Supreme Court recognised privacy as a fundamental right encompassing autonomy and decisional dimensions. Selvi is particularly relevant where technology is used to obtain or interfere with information connected to the mind. These principles can potentially constrain involuntary cognitive or neurological enhancement.

B. European Union / Europe

Europe generally follows a stronger human-rights and precautionary approach.

Important principles include:

bodily integrity;

informed consent;

dignity;

private and family life;

data protection;

non-discrimination;

protection of children;

precaution.

The European Convention on Human Rights is particularly relevant through Articles 8 and 3, while the Oviedo Convention on Human Rights and Biomedicine provides an important European biomedical framework.

European law generally distinguishes legitimate medical treatment from interventions presenting unacceptable risks to human dignity or bodily integrity.

C. United Kingdom

The UK uses a combination of:

Human Fertilisation and Embryology Act 1990, as amended;

Human Rights Act 1998;

medicines and medical-device regulation;

common-law informed consent;

negligence law;

professional medical regulation;

sports anti-doping regulation.

The UK approach is generally permission-based and regulator-driven, especially in reproductive technologies.

The Human Fertilisation and Embryology regulatory structure is particularly significant where enhancement affects embryos, reproductive choices or genetic material.

5. United States

The US has no general federal human-enhancement statute.

Instead, regulation is fragmented among:

FDA regulation;

federal and state medical law;

constitutional rights;

patent law;

disability law;

sports regulation;

privacy law;

tort law;

research regulation.

The United States generally gives substantial weight to individual liberty but simultaneously regulates unsafe medical interventions.

The US Supreme Court's jurisprudence concerning bodily integrity, reproductive decisions, mental treatment and biotechnology therefore becomes important.

6. China

China provides an especially important example because the He Jiankui genome-editing case demonstrated the consequences of reproductive human enhancement.

He Jiankui and co-defendants were convicted in 2019 after using genome-editing technology on human embryos intended for reproduction. He received three years' imprisonment and a fine. (Supreme Court of China)

China subsequently strengthened its regulatory framework. Recent Chinese regulation has moved toward comprehensive lifecycle regulation of new biomedical technologies, including clinical research involving human germ cells, zygotes and embryos. A regulation signed in September 2025 took effect on 1 May 2026. (PMC)

Thus China illustrates a stronger regulatory/administrative model than the fragmented American approach.

7. International Regulatory Philosophy

Human-enhancement law can broadly be divided into four approaches:

1. Libertarian model

Emphasises:

Personal autonomy + freedom of choice

The State should interfere only where substantial harm to others is demonstrated.

2. Precautionary model

Emphasises:

Scientific uncertainty + prevention of irreversible harm

Particularly important for germline genetic enhancement.

3. Human-dignity model

Emphasises:

Human dignity + bodily integrity + prohibition of commodification

Strongly visible in European bioethics.

4. Public-interest/regulatory model

Emphasises:

Safety + professional licensing + ethical review + state supervision

China provides a strong contemporary example.

8. Important Case Laws

Case 1: Selvi v State of Karnataka

(2010) 7 SCC 263 — Supreme Court of India

Facts

The case concerned involuntary use of techniques such as narco-analysis, polygraph examination and brain electrical activation profiling during criminal investigations.

Issue

Whether the State could subject individuals to techniques affecting the mind without their voluntary consent.

Decision

The Supreme Court held that involuntary administration of such techniques violated constitutional protections.

Principle

The Court emphasised:

personal liberty;

mental privacy;

bodily integrity;

protection against compelled testimonial responses;

informed consent.

Relevance to human enhancement

This is one of the most important Indian precedents for neuro-enhancement and cognitive enhancement law.

If technology can alter, stimulate, monitor or manipulate cognitive functioning, mental autonomy becomes legally relevant.

Thus:

Cognitive enhancement cannot be treated simply as an ordinary medical procedure where the intervention substantially affects mental autonomy.

9. Justice K.S. Puttaswamy v Union of India

(2017) 10 SCC 1 — Supreme Court of India

Issue

Whether privacy constitutes a fundamental right under the Constitution.

Decision

The Supreme Court unanimously recognised privacy as a fundamental right.

The judgment connected privacy with:

dignity;

autonomy;

bodily integrity;

decisional freedom;

personal identity.

Relevance

Human enhancement involves extremely intimate choices:

whether to modify one's body;

whether to use genetic technologies;

whether to implant technology;

whether to enhance cognitive abilities;

whether to undergo reproductive intervention.

Therefore, Puttaswamy provides an important constitutional foundation for voluntary enhancement, subject to legitimate limitations.

It also supports protection against:

compulsory enhancement;

unauthorised genetic profiling;

neural-data exploitation;

involuntary biological modification.

10. Riggins v Nevada

504 U.S. 127 (1992) — U.S. Supreme Court

Facts

Riggins was a criminal defendant who was receiving antipsychotic medication. He challenged the forced administration of medication during his trial.

Decision

The Supreme Court held that involuntary administration of antipsychotic medication during the trial required careful constitutional justification.

Principle

The case recognised significant liberty interests concerning forced psychiatric medication.

Human-enhancement relevance

The case is important because it illustrates the legal boundary between:

medical intervention → cognitive alteration → personal autonomy.

The same principle becomes increasingly important with:

neural implants;

cognitive-enhancing drugs;

brain stimulation;

neuroprosthetics.

The State cannot simply assume that altering someone's mental state is legally equivalent to ordinary medical treatment.

11. Sell v United States

539 U.S. 166 (2003) — U.S. Supreme Court

Facts

The government sought to forcibly administer antipsychotic medication to a criminal defendant to make him competent to stand trial.

Decision

The Supreme Court established stringent conditions governing involuntary administration of antipsychotic medication for competency purposes.

Principle

Forced medication requires:

important governmental interests;

medication being substantially likely to achieve those interests;

medication being substantially unlikely to produce significant side effects that interfere with fairness;

consideration of less intrusive alternatives.

Human-enhancement significance

Although this was not an enhancement case, it provides a powerful legal model for determining when the State can interfere with a person's neurological and cognitive condition.

It demonstrates that:

Mental modification is subject to heightened legal scrutiny when it affects autonomy and personality.

12. Association for Molecular Pathology v Myriad Genetics, Inc.

569 U.S. 576 (2013) — U.S. Supreme Court

Facts

Myriad Genetics obtained patents concerning BRCA1 and BRCA2 genes.

Issue

Could naturally occurring human DNA be patented?

Decision

The Supreme Court held that naturally occurring DNA segments are products of nature and are not patent-eligible merely because they have been isolated. However, synthetically created cDNA could qualify for patent protection. (Legal Information Institute)

Human-enhancement relevance

The case establishes an important boundary between:

human biological material existing in nature

and

human-created biological technology.

It is significant for future enhancement technologies involving:

synthetic genes;

engineered DNA;

genetic therapies;

biological enhancement;

genetic patents.

The Court expressly distinguished naturally occurring genetic material from technologically created genetic constructs. (Legal Information Institute)

13. Davis v Davis

842 S.W.2d 588 (Tenn. 1992) — Supreme Court of Tennessee

Facts

A divorcing couple disagreed over the disposition of embryos created through IVF.

Issue

Who should determine the fate of cryopreserved embryos?

Decision

The court treated the embryos as occupying a special legal category rather than simply being ordinary property or full legal persons.

Principle

The court balanced:

reproductive autonomy;

interests of both genetic contributors;

future reproductive consequences.

Human-enhancement relevance

Although primarily an assisted-reproduction case, it is important for enhancement law because future reproductive technologies may allow:

embryo genetic modification;

embryo selection;

disease-risk modification;

enhancement of physical characteristics.

It demonstrates that reproductive autonomy has to be balanced between genetic contributors and the future implications of technological intervention. The case is also discussed in comparative reproductive jurisprudence concerning embryo status. (Open Casebook)

14. Evans v United Kingdom

App. No. 6339/05, ECtHR Grand Chamber, 10 April 2007

Facts

Natallie Evans underwent IVF before treatment for cancer that would leave her infertile. Embryos were created with her partner's sperm. After their relationship ended, the partner withdrew his consent to their continued use.

Issue

Could Evans use the embryos despite her former partner's withdrawal of consent?

Decision

The European Court of Human Rights held that Article 8 was engaged but accepted the UK's continuing-consent system.

Principle

The case recognised that Article 8 encompasses decisions concerning:

whether to become a parent;

whether not to become a parent;

reproductive autonomy.

But those interests may conflict.

The Court afforded the State a considerable margin of appreciation. (New Law Journal)

Enhancement relevance

This case becomes significant where genetic enhancement involves:

embryos;

parental consent;

reproductive autonomy;

embryo modification;

competing parental wishes.

15. S.H. and Others v Austria

ECtHR Grand Chamber, App. No. 57813/00, 3 November 2011

Facts

The applicants challenged Austrian restrictions concerning assisted reproduction and gamete donation.

Issue

Whether restrictions on assisted reproduction violated Article 8.

Decision

The Grand Chamber gave the State a relatively broad margin of appreciation and accepted that differing European approaches to reproductive technologies could coexist.

Relevance

The case demonstrates that European law does not necessarily require one uniform model of reproductive biotechnology.

This becomes important when enhancement technologies cross borders:

A technology lawful in one jurisdiction may be restricted or prohibited in another.

The case is recognised as an important European precedent concerning medically assisted reproduction and national regulatory diversity. (ScienceDirect)

16. Marin Cilic v International Tennis Federation

CAS 2013/A/3327 & CAS 2013/A/3335, Award 11 April 2014

Facts

Tennis player Marin Cilic tested positive for a prohibited substance after consuming a product he believed was permissible.

Issue

How should responsibility and sanction be determined where an athlete unintentionally uses a prohibited substance?

Decision

The Court of Arbitration for Sport developed a structured approach to assessing the athlete's degree of fault and emphasised proportionality in determining sanctions. (Scribd)

Human-enhancement relevance

Sports law provides one of the clearest existing regulatory models for human enhancement.

Performance-enhancing substances demonstrate the difference between:

ordinary medical improvement

and

enhancement that creates an unfair competitive advantage.

The legal system may therefore restrict enhancement even where an athlete voluntarily consents to it.

17. Association for Molecular Pathology and Genetic Enhancement

An important conceptual distinction emerges from Myriad:

Myriad therefore does not itself decide whether gene enhancement is lawful. Its significance lies in the legal treatment of biological information and human-created genetic material. (Legal Information Institute)

18. He Jiankui Genome-Edited Babies Case

Although this was a criminal proceeding rather than a conventional appellate precedent, it is essential to comparative human-enhancement law.

Facts

He Jiankui used CRISPR-Cas9 to edit the CCR5 gene in human embryos with the stated objective of reducing susceptibility to HIV.

The embryos were implanted and genetically edited children were born.

Legal response

Chinese authorities found serious violations involving:

reproductive medical regulation;

research ethics;

professional qualifications;

informed consent;

human embryo experimentation.

He was sentenced to three years' imprisonment and fined RMB 3 million. (Supreme Court of China)

Legal significance

The case illustrates why germline enhancement is treated differently from ordinary somatic treatment.

A somatic intervention primarily affects the treated person.

A germline intervention may affect:

the treated person + descendants + future generations.

China subsequently strengthened its legislative framework concerning human genome and embryo research. (PubMed)

19. Comparative Case-Law Table

20. Therapy vs Enhancement

This distinction is central.

Therapy

Example:

CRISPR is used to correct a mutation causing a severe inherited disease.

Objective:

restore normal biological functioning.

Enhancement

Example:

CRISPR is used to increase muscle strength in an otherwise healthy person.

Objective:

create a biological advantage beyond ordinary health.

Grey area

Suppose a person has a gene associated with unusually low muscle strength but does not have a recognised disease.

Gene editing to increase muscle capacity could be characterised either as:

treatment;

prevention;

enhancement.

Therefore, legal classification may depend upon the baseline of normal functioning and the purpose of the intervention.

21. Major Legal Principles

A. Autonomy Principle

A competent adult should ordinarily have substantial authority over their own body.

But autonomy is not unlimited.

Restrictions can be justified where enhancement:

seriously endangers others;

creates substantial public-health risks;

involves exploitation;

violates professional standards;

affects children;

affects future generations.

B. Informed Consent

Enhancement requires meaningful consent.

Consent should ordinarily disclose:

nature of technology;

purpose;

expected benefit;

known risks;

uncertain risks;

alternatives;

reversibility;

long-term consequences;

financial implications;

data/genetic information consequences.

This becomes particularly difficult where technology is experimental.

22. Future Generations Principle

The strongest legal objection to germline enhancement is that:

the person who bears the consequences cannot consent to the intervention.

A child born after germline modification may inherit:

intended genetic changes;

unintended mutations;

unknown health effects.

The intervention can also affect descendants.

Therefore, future-generations law becomes connected with human-enhancement law.

23. Equality and Enhancement

Human enhancement could produce a new social divide:

Unenhanced humans

versus

Enhanced humans

For example:

enhanced cognitive capacity;

enhanced physical strength;

improved memory;

extended lifespan;

genetic disease resistance.

If enhancement is expensive, society could develop:

biological inequality based on wealth.

Therefore, equality law may eventually need to address whether enhanced characteristics can lawfully be used in:

employment;

education;

insurance;

sports;

military service;

public office.

24. Human Enhancement and Employment

Employers might theoretically seek:

drug-enhanced concentration;

fatigue resistance;

neural monitoring;

genetic screening;

memory enhancement.

This raises major questions:

Can an employer require enhancement?

Generally, compulsory biological modification would raise serious autonomy and privacy concerns.

Can an employer discriminate against an unenhanced employee?

Potentially problematic where the distinction lacks legitimate justification.

Can employees demand enhancement?

That depends upon the medical, employment and equality framework applicable to the jurisdiction.

25. Human Enhancement and Sports

Sports provide the most developed regulatory model.

The central principle is:

Competition should measure athletic performance rather than access to prohibited artificial advantages.

Enhancement can be restricted through:

anti-doping rules;

prohibited substances lists;

biological monitoring;

sanctions;

suspension;

disqualification.

The Cilic decision demonstrates how proportionality and degree of fault can affect sanctions. (Scribd)

26. Human Enhancement and Children

Children create a much more difficult legal problem.

Parents ordinarily make medical decisions for children, but enhancement is different from treatment.

Medical treatment

Parents may authorise treatment because it benefits the child's health.

Enhancement

If the procedure merely makes the child:

taller;

stronger;

more intelligent;

more resistant to fatigue;

the justification becomes considerably more difficult.

The law therefore needs to distinguish:

best interests of the child

from

parental desire for a technologically improved child.

27. Human Enhancement and Artificial Intelligence

Future enhancement may combine:

Human + AI + biotechnology + neural interface.

Examples:

brain-computer interfaces;

AI-assisted memory;

neural implants;

artificial vision;

cognitive prostheses;

AI-controlled prosthetic limbs.

This creates additional questions:

Who owns neural data?

Can the implant be hacked?

Who is responsible for an AI-assisted decision?

Can a person remove an implanted system?

What happens if the manufacturer stops supporting it?

Is neural data more sensitive than ordinary personal data?

Can employers demand access to cognitive-performance information?

28. Comparative Models

29. Major Legal Challenges

1. Defining “normal”

Law needs a baseline.

If technology makes a person stronger than average, is that treatment or enhancement?

There is no universally accepted answer.

2. Rapid technological change

Legislation moves slowly while biotechnology changes rapidly.

3. Cross-border enhancement tourism

People may travel to jurisdictions where enhancement is less regulated.

4. Consent of future generations

Germline enhancement creates the deepest consent problem.

5. Economic inequality

Enhancement may become available primarily to wealthy populations.

6. Insurance discrimination

Insurers might want access to genetic or enhancement information.

7. Employment discrimination

Employers might prefer enhanced workers.

8. Military enhancement

Soldiers could be subjected to:

stimulants;

gene modification;

neural enhancement;

fatigue suppression.

This creates particularly serious autonomy questions.

30. Emerging Legal Principle: Enhancement Must Be Proportionate

A useful comparative framework is:

Legitimate objective → Scientific evidence → Informed consent → Least intrusive intervention → Risk assessment → Equality assessment → Oversight → Accountability

An enhancement should become legally suspect when:

risks are unknown;

consent is coerced;

effects are irreversible;

the subject is a child;

descendants are affected;

there is serious discrimination;

commercial interests dominate;

independent ethical review is absent.

31. Difference Between Enhancement and Human Experimentation

A single procedure may be both experimental and enhancing, making regulatory safeguards particularly important.

32. Liability for Harmful Enhancement

If an enhancement causes injury, several forms of liability may arise.

Medical negligence

Failure to meet professional standards.

Product liability

Defective enhancement device, drug or implant.

Informed-consent liability

Failure to disclose material risks.

Contractual liability

Failure to provide promised enhancement.

Consumer protection

Misleading claims such as:

“Guaranteed intelligence enhancement.”

Criminal liability

Potentially where the intervention is unlawful or recklessly performed.

Constitutional liability

Potentially where government authorities compel or unlawfully interfere with enhancement-related choices.

33. The Four-Level Regulatory Model

A future human-enhancement regime could operate at four levels:

Level 1 — Individual autonomy

Protect competent adults' choices.

Level 2 — Safety regulation

Require:

clinical trials;

ethical review;

licensing;

monitoring.

Level 3 — Social justice

Prevent:

discrimination;

exploitation;

enhancement-based exclusion;

extreme inequality.

Level 4 — Intergenerational protection

Apply heightened restrictions to:

germline editing;

irreversible embryo modification;

interventions affecting descendants.

34. Critical Comparative Analysis

The Indian model is primarily constitutional and sectoral. Cases such as Puttaswamy and Selvi supply principles of autonomy, privacy and mental integrity, but India does not yet have a unified enhancement code.

The European model is more explicitly grounded in dignity, bodily integrity, privacy and precaution. Reproductive cases such as Evans and S.H. demonstrate the importance of balancing individual reproductive autonomy with regulatory discretion.

The US model places greater emphasis on individual liberty but relies heavily on fragmented federal/state regulation. Riggins, Sell, Davis and Myriad demonstrate how different branches of law address mental intervention, reproduction and biotechnology.

The Chinese model illustrates strong state supervision. The He Jiankui case triggered significant regulatory development, and China has continued strengthening regulation of biomedical technologies, including technologies involving human germ cells and embryos. (PMC)

Sports law represents a separate model in which enhancement can be prohibited even when voluntarily chosen because of fairness and integrity of competition.

35. Important Case-Law Principles at a Glance

36. Future of Human Enhancement Law

Future regulation is likely to focus on five major areas:

1. Genetic enhancement

Especially:

germline editing;

embryo modification;

genetic selection;

designer traits.

2. Neurotechnology

Including:

brain-computer interfaces;

memory enhancement;

cognitive augmentation;

neural-data protection.

3. Human-machine integration

Including:

robotic limbs;

artificial organs;

neural implants;

AI-integrated prostheses.

4. Longevity

Legal questions may arise concerning:

anti-ageing therapies;

access to life-extension technologies;

healthcare equality;

intergenerational resource allocation.

5. Enhancement discrimination

Future law may have to answer:

Can a person be denied employment, education, insurance or public benefits because they are enhanced—or because they are not enhanced?

37. Conclusion

Comparative Human Enhancement Law is an emerging field rather than a fully established independent branch of law. It lies at the intersection of constitutional law, medical law, bioethics, human rights, reproductive law, intellectual property, criminal law, tort law, privacy law and sports law.

The central legal tension is:

Individual freedom to improve oneself vs. collective responsibility to prevent harm, inequality, coercion and irreversible consequences.

The most important comparative principles are:

Autonomy + Informed Consent + Human Dignity + Safety + Equality + Precaution + Non-Discrimination + Intergenerational Justice + Accountability.

For ordinary voluntary enhancement of a competent adult, the law is likely to give substantial weight to autonomy.

For children, involuntary enhancement, experimental enhancement and germline enhancement, legal scrutiny becomes substantially stronger.

The He Jiankui case demonstrates the potential criminal consequences of uncontrolled reproductive genome editing, while Selvi, Puttaswamy, Riggins and Sell provide the foundation for protecting mental and bodily autonomy. Davis, Evans and S.H. demonstrate the complexity of reproductive technologies, while Myriad illustrates the legal boundary between natural human biology and human-created genetic technology. Sports jurisprudence such as Cilic shows that voluntary enhancement may nevertheless be prohibited when it undermines a legally protected system such as competitive fairness. (Supreme People's Court)

Exam-ready definition

Human Enhancement Law is the body of constitutional, medical, technological, reproductive, regulatory and human-rights principles governing interventions that seek to improve or augment human physical, cognitive, genetic, reproductive or sensory capacities beyond ordinary therapeutic restoration, while balancing individual autonomy against safety, dignity, equality, public interest and the rights of future generations.

Key formula:

Human Enhancement Law = Autonomy + Consent + Safety + Dignity + Equality + Precaution + Accountability + Intergenerational Protection.